The FDA approved a new tuberculosis drug that improves treatment for the hardest-to-treat cases. Drug-resistant TB is a growing problem in many poor countries.
. In a clinical trial that enrolled 109 patients in South Africa, the three-pill combo cured about 90% of patients with very drug-resistant TB, usually within six months. More than 10% of patients experienced side effects, including nausea, vomiting, anemia and and a type of nerve damage calledThe drug regimen also appears to stop patients spreading the deadly bacterial infection after a few days’ treatment.
“Amazingly, it’s the first time that a treatment for XDR-TB infections has been recognized for actually working — no other treatment has demonstrated any consistent effectiveness,” Jamie Bay Nishi, director of the
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Drinking bleach will not cure cancer or autism, FDA warnsTaking 'Miracle Mineral Solution' and other similar products is the same as drinking bleach, the FDA said.
Leer más »
FDA warns about 'miracle' solution claiming to cure autism, cancer: 'Same as drinking bleach'The Food and Drug Administration is warning people against buying or using “Miracle Mineral Solution” — a product being sold online as a remedy for cancer.
Leer más »
FDA issues warning not to drink bleach to cure cancer, autism
Leer más »
FDA warns against drinking Mineral Miracle Solution, says it's 'the same as bleach'Federal government again warns against drinking Mineral Miracle Solution—which has been promoted on social media as a treatment for numerous conditions, including autism and cancer—saying it's 'the same as bleach.'
Leer más »
FDA releases warning about 'miracle' solution claiming to cure autism, cancer: 'The same as drinking bleach'“Miracle Mineral Solution and similar products are not FDA-approved, and ingesting these products is the same as drinking bleach,” FDA acting commissioner Ned Sharpless, M.D., said in a statement.
Leer más »